A week after Covid-19 vaccine trial goes on pause, Johnson & Johnson and FDA won’t reveal critical details

Despite repeated claims they’re committed to transparency, Johnson & Johnson and the US Food and Drug Administration still aren’t revealing crucial details one week after the pharmaceutical giant’s Covid-19 vaccine trial went on pause.